Αρχική World News Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics... World News Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Από Ogkologos - 6 Οκτωβρίου, 2026 77 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PATHFINDER 2 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ EMA recommends granting a marketing authorisation for daraxonrasib Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? MOST POPULAR EMA Recommends Granting a Marketing Authorisation for the Hybrid Medicine Imatinib 29 Ιουλίου, 2021 Teclistamab Significantly Improves Survival Among Patients with Multiple Myeloma Who Previously... 16 Ιουνίου, 2026 Study Shows Supplements Increase Risk of Relapse and Death in Breast... 7 Ιανουαρίου, 2020 Take with Food: Study Tests Lowering Dose of Prostate Cancer Drug 23 Απριλίου, 2018 Φόρτωση περισσοτέρων HOT NEWS Low Risk of Cardiotoxicity with Immune Checkpoint Inhibitor Monotherapy or Combination... What’s happened to cancer clinical trials during the COVID-19 pandemic? Man Spent 20 Years Tracking Down And Buying His Late Mother’s... Coronavirus reports – Part 6 “The kids being home all the...